Pfizer Stock

Pfizer EBIT

The EBIT of Pfizer (PFIZER.NS) as of Jul 25, 2026 is 6.94 B INR. In the previous year, EBIT was 5.83 B INR — a change of 18.93% (higher).

EBIT

6.94 BINR

YoY

18.93%

Last updated:

In 2026, Pfizer's EBIT was 6.94 B INR, a 18.93% increase from the 5.83 B INR EBIT recorded in the previous year.

The Pfizer EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B INR)
Date
EBIT (B INR)
Jan 1, 2021
6.10 base
Jan 1, 2022
7.30 base
Jan 1, 2023
7.12 base
Jan 1, 2024
5.83 base
Jan 1, 2025
6.94 base
Jan 1, 2026 (e)
9.21 base
Jan 1, 2027 (e)
10.30 base
Jan 1, 2028 (e)
10.78 base
YEAREBIT (B INR)
2028 est 10.78
2027 est 10.30
2026 est 9.21
2025 6.94
2024 5.83
2023 7.12
2022 7.30
2021 6.10
2020 4.83
2019 5.07
2018 4.45
2017 2.95
2016 3.89
2015 2.71
2014 2.46
2013 -6.88
2012 -10.53
2011 2.60
2009 2.94
2008 -4.25
2007 2.96
2006 1.52
2005 1.18
Access this data via the Eulerpool API

Pfizer Revenue

Pfizer Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
22.39 B INR
6.10 B INR
4.98 B INR
Jan 1, 2022
26.11 B INR
7.30 B INR
6.13 B INR
Jan 1, 2023
24.25 B INR
7.12 B INR
6.24 B INR
Jan 1, 2024
21.93 B INR
5.83 B INR
5.51 B INR
Jan 1, 2025
22.81 B INR
6.94 B INR
7.68 B INR
Jan 1, 2026 (e)
25.64 B INR
9.21 B INR
7.71 B INR
Jan 1, 2027 (e)
27.89 B INR
10.30 B INR
8.48 B INR
Jan 1, 2028 (e)
30.29 B INR
10.78 B INR
9.33 B INR

Pfizer Margins

Pfizer stock margins

The Pfizer margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pfizer. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pfizer.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
61.64 %
27.27 %
22.23 %
Jan 1, 2022
61.37 %
27.96 %
23.46 %
Jan 1, 2023
61.74 %
29.38 %
25.73 %
Jan 1, 2024
61.61 %
26.60 %
25.14 %
Jan 1, 2025
62.34 %
30.41 %
33.65 %
Jan 1, 2026 (e)
62.34 %
35.91 %
30.05 %
Jan 1, 2027 (e)
62.34 %
36.92 %
30.41 %
Jan 1, 2028 (e)
62.34 %
35.59 %
30.81 %

Pfizer Stock analysis

What does Pfizer do? Pfizer Ltd is a global biopharmaceutical company based in New York City, USA. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart, and has achieved numerous milestones in the pharmaceutical industry during its 170-year history. Pfizer's business model is based on the research, development, production, and distribution of innovative drugs and vaccines for a variety of diseases. With a diverse portfolio of products, the company's range extends from drugs for cancer, inflammation, and immunology to neurological and cardiology conditions. Pfizer is a global leader in the development of cancer drugs and has achieved groundbreaking research successes in recent years. Key divisions of the company include oncology, pain management, cardiology, and neurology. Pfizer places great emphasis on putting patients and their needs at the center and works closely with medical professionals, patient groups, and authorities to ensure the best possible patient care. Pfizer is a leading provider of vaccines and has achieved significant breakthroughs in the development of COVID-19 vaccines in recent years. In December 2020, the company was one of the first worldwide to bring a vaccine against the coronavirus to market, making a significant contribution to the fight against the pandemic. In addition to drug research and development, Pfizer is also heavily involved in corporate social responsibility. The company is committed to sustainable development and continuously works to reduce its carbon footprint. The Pfizer Foundation also supports numerous nonprofit organizations and projects in the areas of health, education, and environmental protection. Among Pfizer's most well-known products are medications such as Viagra, Lipitor, and Lyrica, as well as the COVID-19 vaccine Comirnaty. Pfizer has offices in over 150 countries and employs over 90,000 people worldwide. Like any global company, Pfizer faces challenges. The company is often criticized for high drug prices and the availability of medications in developing countries. However, Pfizer actively advocates for access to affordable healthcare and delivers drugs and vaccines to all regions of the world. Overall, Pfizer is a company of great importance in the global healthcare industry. Through its research and development of innovative drugs and vaccines, the company contributes to improving the quality of life for millions of people worldwide. Pfizer is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Pfizer's EBIT

Pfizer's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Pfizer's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Pfizer's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Pfizer’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Pfizer stock

EBIT of Pfizer is 6.94 B INR in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Pfizer

All Key Metrics — Pfizer